| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |